Why Hybrid-Ultimate® Combines HA Spreadability With Gentle PLLA Collagen Stimulation

Author: Dr Sef BMBS, BSc

GMC Registered Doctor

AIVA Wellness Clinical Team

Medically reviewed by: Dr Raheem MBChB, MRCGP

GMC Registered Doctor

AIVA Wellness Clinical Team

Last reviewed: August 2026

Clinical overview

Hybrid-Ultimate® penis filler represents a fundamental shift in non-surgical penis enlargement and penile girth enhancement. Engineered specifically for male genital aesthetics, it combines a high-viscosity, densely cross-linked hyaluronic acid (HA) matrix with a hyperdilute, micronised poly-L-lactic acid (PLLA) biostimulatory component.

By using HA as the primary structural vehicle for immediate circumferential volume and incorporating hyperdilute PLLA for gradual, secondary neocollagenesis, Hybrid-Ultimate® solves the primary limitations of single-agent injectables: the temporary and very soft nature of pure HA, and the unpredictable nodule risks historically associated with standalone, highly concentrated PLLA.

The evolution beyond pure HA

At Aiva Wellness, our clinical team has performed non-surgical penis filler procedures for over eight years. During the first half of that decade, pure hyaluronic acid was the global benchmark for non-surgical penis enlargement. HA offered immediate gratification, high mouldability, and a known safety profile backed by enzymatic reversibility via hyaluronidase.

However, eight years of long-term patient follow-ups revealed consistent physiological limitations:

• Pure volumetric reliance: Pure HA acts strictly as an inert space-occupying gel. Once the gel naturally degrades through enzymatic pathways and mechanical compression during erection and intercourse, the added girth diminishes entirely and goes very soft and "mushy" — not ideal for the erect penis.
• Tissue adaption and dispersal: Over time, repeated shear forces across the penile shaft can cause softer HA gels to compress, requiring frequent, high-volume top-ups to maintain initial girth.

The clinical verdict: If pure HA alone delivered superior, long-lasting structural results, we would continue offering it as a standalone option today. However, relying exclusively on HA is simply inferior to modern hybrid technology. We have retired standalone HA for penis girth enlargement because patients deserve long-term biological tissue integration rather than the temporary volumetric water retention that HA essentially becomes over time.

Overcoming the misuse of historical PLLA

Poly-L-lactic acid (PLLA) is one of the most potent collagen-stimulating biomaterials in regenerative medicine. However, its historical application in aesthetic medicine — particularly when used in high concentrations or improperly reconstituted — earned a reputation for variable outcomes.

The historical problem with standalone PLLA

In early aesthetic applications, standalone PLLA was frequently injected in high particle concentrations with insufficient hydration volume. Without an immediate, cohesive carrier matrix, concentrated PLLA microparticles tended to clump, resulting in palpable subcutaneous nodules, focal fibrotic granulomas, and uneven contouring — issues particularly unacceptable in the elastic, mobile anatomy of the penile shaft.

The Hybrid-Ultimate® solution: hyperdilution in an HA matrix

Hybrid-Ultimate® completely overcomes these historical pitfalls:

1. Hyperdilution: PLLA microparticles are processed into a hyperdilute concentration, calibrated to signal a gentle, broad-spectrum biological response rather than aggressive, focal stimulation.
2. Suspension matrix: The PLLA particles are uniformly dispersed within a high-cohesivity HA gel matrix. This prevents particle migration, eliminates clump formation, and ensures that the biostimulatory signal is distributed in a smooth, continuous layer across the entire penile shaft.

The science of HA spreadability and penile rheology

An effective penis filler must accommodate the mechanical transition between flaccid and erect states without creating visible ridges, firm nodules, or unnatural segmentation. Achieving this requires precise rheological engineering.

Human histological and bio-integration studies demonstrate that an HA filler's viscoelastic properties dictate how evenly it integrates between fascial planes. Softer, low-cohesivity fillers risk uncontrolled displacement, whereas excessively rigid fillers remain in defined, unnatural aggregates.

Hybrid-Ultimate® balances high elastic modulus (G') with optimal cohesivity, allowing the filler to spread continuously along the sub-Dartos plane during intra-procedural moulding while resisting post-treatment displacement.

The landmark CDS technique: Dr Sef and Dr Raheem's single-entry injection protocol

Achieving an optimal aesthetic result with penis filler depends as much on delivery technique as on product rheology. Traditional multi-puncture needle techniques introduce multiple entry points, increasing the risk of haematoma, distal oedema, uneven distribution, and filler migration.

To establish a safer, more uniform standard, Dr Sef published a landmark clinical case report introducing the Cylindrical Dartos-Buck Smooth (CDS) technique using Aiva® Hybrid-Ultimate.

Key highlights of the published CDS case report

• Single-point access: The procedure uses an 18-G blunt-tip cannula introduced through a single pilot entry point at the mid-shaft, eliminating unnecessary tissue trauma.
• Sub-Dartos deposition: Filler is deposited precisely within the anatomical space between Dartos fascia and Buck's fascia, avoiding superficial dermal placement or deep vascular structures.
• Pulsed retrograde micro-droplets: Hybrid-Ultimate® is delivered using a pulsed retrograde technique, creating structured micro-droplet "anchor points" that secure the filler matrix and resist distal migration.
• Clinical outcomes: At six-month follow-up, clinical evaluation demonstrated a uniform 0.63-inch (approx. 1.6 cm) girth increase, natural tactile softness in both flaccid and erect states, zero nodule formation, and exceptional patient satisfaction scores.

Why Hybrid-Ultimate® is "the ultimate" choice

Hybrid-Ultimate® combines immediate structural volume with long-term tissue conditioning, creating a dual-phase augmentation strategy:

1. Immediate structural architecture: The densely cross-linked HA matrix provides immediate, predictable girth expansion that can be massaged and contoured during consultation.
2. Progressive endogenous neocollagenesis: Human biopsy and experimental studies confirm that injectable PLLA microparticles stimulate progressive Type I and Type III collagen synthesis over 3 to 6 months.
3. Sustained tissue density: As the HA component undergoes natural enzymatic degradation over 12 to 24 months, newly synthesised host collagen fills the matrix space, maintaining tissue density and natural firmness far beyond standard pure-HA duration.

Reversibility vs. adjustability: honest clinical transparency

A central principle of responsible medical practice is clear patient communication regarding product reversibility.

Clinical note on reversibility

Hybrid-Ultimate® should not be marketed as 100% reversible. It is accurately described as highly adjustable. Because the majority volume of Hybrid-Ultimate® consists of cross-linked HA, acute asymmetry, overcorrection, or unwanted gel deposits can be effectively dissolved using targeted hyaluronidase injections.

However, hyaluronidase only hydrolyses hyaluronic acid; it does not degrade:

• PLLA microparticles;
• neocollagen formed by host fibroblasts;
• pre-existing or newly integrated collagenous tissue.

This distinction gives Hybrid-Ultimate® significant safety advantages over permanent synthetic implants or non-dissolvable gels while retaining the long-term benefits of biostimulation.

Safety profile and clinical rationale at Aiva Wellness

Non-surgical penis enlargement with injectable fillers remains an off-label indication in the UK. Safe outcomes rely entirely on practitioner expertise, sterile protocols, and advanced product selection.

Potential complications and mitigation strategies

• Transient oedema and ecchymosis: Minimised by using blunt-tip cannulae via a single entry point (CDS technique).
• Asymmetry or nodule formation: Controlled by utilising pre-mixed hyperdilute PLLA within high-cohesivity HA, preventing particle clumping.
• Product migration: Avoided by depositing filler exclusively within the sub-Dartos plane, distal to the circumcision scar, using pulsed micro-droplet anchors.
• Infection and inflammatory responses: Managed through rigorous aseptic preparation and strict post-treatment aftercare protocols.

View Before & After Gallery

Book Penis Filler Consultation

Frequently asked questions

Is Hybrid-Ultimate® superior to standard pure HA penis fillers?

Yes. While pure HA fillers provide immediate results, they act purely as temporary space-occupying gels. Having performed pure HA procedures for over eight years, our clinical finding is that pure HA lacks long-term structural tissue support. Hybrid-Ultimate® provides both immediate volume and progressive collagen building, making it a far superior long-term solution.

How does the CDS single-entry technique improve safety?

The CDS technique uses a single pilot entry point with a blunt-tip cannula. This eliminates multiple needle punctures, dramatically reduces the risk of bruising and vascular trauma, and ensures precise, continuous placement within the sub-Dartos fascial layer.

Can PLLA cause hard lumps or nodules in the penis?

Historically, standalone PLLA-only fillers which had not been diluted carried a nodule risk if under-diluted or injected unevenly. Hybrid-Ultimate® solves this by using a hyperdilute PLLA concentration uniformly suspended inside an HA gel matrix, ensuring smooth dispersion without clumping.

Can Hybrid-Ultimate® be dissolved with hyaluronidase?

The HA component — which makes up the vast majority of the volume — can be dissolved with hyaluronidase if adjustment is needed. However, the new collagen produced by your body in response to the PLLA component cannot be dissolved by hyaluronidase.

How long do the results of Hybrid-Ultimate® last?

While standard HA fillers typically require top-ups within 9 to 12 months, the biostimulatory collagen framework generated by Hybrid-Ultimate® helps maintain structural tissue density and natural girth significantly longer. Individual retention depends on patient metabolism and tissue integration.

References

1. Sundaram H, Cassuto D. Biophysical characteristics of hyaluronic acid soft-tissue fillers and their relevance to aesthetic applications. Plast Reconstr Surg. 2013;132(4 Suppl 2):5S–21S. doi:10.1097/PRS.0b013e31829d1d40.
2. Tran C, Carraux P, Micheels P, Kaya G, Salomon D. In vivo bio-integration of three hyaluronic acid fillers in human skin: a histological study. Dermatology. 2014;228(1):47–54. doi:10.1159/000354384.
3. Yang DY, Ko K, Lee SH, Lee WK. A comparison of the efficacy and safety between hyaluronic acid and polylactic acid filler injection in penile augmentation: a multicenter, patient/evaluator-blinded, randomized trial. J Sex Med. 2019;16(4):577–585. doi:10.1016/j.jsxm.2019.01.310.
4. Yang DY, Jeong HC, Ahn ST, et al. A comparison between hyaluronic acid and polylactic acid filler injections for temporary penile augmentation in patients with small penis syndrome: a multicenter, patient/evaluator-blind, comparative, randomized trial. J Sex Med. 2020;17(1):133–141. doi:10.1016/j.jsxm.2019.10.006.
5. Yang DY, Jeong HC, Ko K, et al. Comparison of clinical outcomes between hyaluronic and polylactic acid filler injections for penile augmentation in men reporting a small penis: a randomized comparative trial with 18 months of follow-up. J Clin Med. 2020;9(4):1024. doi:10.3390/jcm9041024.
6. Jones D, Tezel A, Borrell M. The kinetics of reversible hyaluronic acid filler injection treated with hyaluronidase. Dermatol Surg. 2018;44(2):226–231. doi:10.1097/DSS.0000000000001084.
7. Moon DG, Cho SB, Ahn ST. Managing residual volumes in penile girth enhancement with hyaluronic acid fillers: a case series and literature review. Int J Impot Res. 2025. doi:10.1038/s41443-025-01182-8.
8. Goldberg D, Guana A, Volk A, Daro-Kaftan E. Single-arm study for the characterization of human tissue response to injectable poly-L-lactic acid. Dermatol Surg. 2013;39(6):915–922. doi:10.1111/dsu.12164.
9. Yu H, Zhang YL, Chen Y, Dong YX, Hong WJ, Luo SK. In vivo effectiveness of poly-L-lactic acid microsphere dermal fillers in stimulating collagen synthesis. Aesthetic Plast Surg. 2025;49(13):3803–3813. doi:10.1007/s00266-025-04839-3.
10. Chaudhry M, Chaudhry A. A novel application of a single-entry injection technique for non-surgical penile enlargement: a case report. Cureus. 2025;17(5):e83712.

Editorial policy

Content published by Aiva Wellness is authored and reviewed by registered UK medical practitioners. Our statements reflect published peer-reviewed literature, biomechanical material science, and extensive clinical experience in male aesthetic medicine.

Medical disclaimer

This article is intended for educational purposes only and does not constitute formal medical advice. Non-surgical penis enlargement using injectable fillers is an off-label medical procedure in the UK. Individual suitability, risks, and clinical outcomes must be evaluated during a face-to-face medical consultation with a qualified physician.

Conflict-of-interest disclosure

Hybrid-Ultimate® is a proprietary formulation utilised by Aiva Wellness. Dr Sef and Dr Raheem are affiliated with Aiva Wellness and hold commercial interests in the clinical protocols discussed.